About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
COMPANY NEWS
Company
News
Abbott India Ltd.
Change Company
BSE Code
500488
ISIN Demat
INE358A01014
Book Value
1657.05
NSE Code
ABBOTINDIA
Dividend Yield %
1.43
Market Cap
608531.14
P/E
47.37
EPS
604.57
Face Value
10
1 Week
1 Month
3 Months
6 Months
1 Year
29-Nov-2024
Abbott India rises on launching Pneumococcal Conj...
28-Nov-2024
Abbott India launches Pneumococcal Conjugate Vacc...
08-Nov-2024
Abbott India informs about issuance of duplicate ...
05-Nov-2024
Abbott India informs about loss of share certific...
18-Oct-2024
Abbott India informs about change in management
11-Oct-2024
Abbott India informs about compliances-certificat...
26-Sep-2024
Abbott India informs about trading window closure
20-Sep-2024
Abbott India signs patent license agreement with ...
31-Aug-2024
Abbott India informs about updates
30-Jul-2024
Abbott India informs about board meeting
23-Jul-2024
Abbott India informs about change in management
11-Jun-2024
Abbott India informs about resignation of director
12-Apr-2024
Abbott India informs about appointment of senior ...
27-Mar-2024
Abbott India informs about newspaper advertisement
19-Mar-2024
Abbott India informs about resignation of managin...
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.